Article Details
Retrieved on: 2018-05-04 07:03:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Bristol-Myers Squibb's three-year collaboration with <b>Flatiron Health</b> will focus on leveraging real-world data to improve the pharmaceutical company's regulatory submissions, demonstrate the economic value of BMS's cancer portfolio, and to study the predictive value of biomarkers. “Contemplating ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here